Literature DB >> 26259979

Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives.

Jaime Guevara-Aguirre1, Patricio Procel2, Carolina Guevara2, Marco Guevara-Aguirre2, Verónica Rosado2, Enrique Teran3.   

Abstract

In the present pandemics of obesity and insulin resistant diabetes mellitus (DM), the specific contribution of etiological factors such as shifts in nutritional and exercise patterns, genetic and hormonal, is subject of ongoing research. Among the hormonal factors implicated, we selected obesity-driven insulin resistance for further evaluation. It is known that growth hormone (GH) has profound effects on carbohydrate metabolism. In consequence, we compared the effects of the lack of the counter-regulatory effects of GH, in a group of subjects with GH receptor deficiency (GHRD) due to a mutated GH receptor vs. that of their normal relatives. It was found that, despite their obesity, subjects with GHRD, have diminished incidence of diabetes, lower glucose and insulin concentrations, and lower values of indexes indicative of insulin resistance such as HOMA-IR. The GHRD subjects were also capable of appropriately handling glucose or mixed meal loads despite diminished insulin secretion. These observations allow us to suggest that the association of obesity with increased risk for diabetes appears to be dependent on intact growth hormone signaling.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Growth hormone; Growth hormone receptor; Growth hormone receptor deficiency; Laron syndrome

Mesh:

Substances:

Year:  2015        PMID: 26259979     DOI: 10.1016/j.ghir.2015.08.002

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  5 in total

1.  Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.

Authors:  Kevin C Corbit; Camella G Wilson; Dylan Lowe; Jennifer L Tran; Nicholas B Vera; Michelle Clasquin; Aras N Mattis; Ethan J Weiss
Journal:  JCI Insight       Date:  2019-08-08

2.  Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling.

Authors:  Kevin C Corbit; João Paulo G Camporez; Lia R Edmunds; Jennifer L Tran; Nicholas B Vera; Derek M Erion; Rahul C Deo; Rachel J Perry; Gerald I Shulman; Michael J Jurczak; Ethan J Weiss
Journal:  Diabetes       Date:  2017-12-04       Impact factor: 9.461

3.  Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study.

Authors:  Ada P Lee; Kathleen Mulligan; Morris Schambelan; Elizabeth J Murphy; Ethan J Weiss
Journal:  F1000Res       Date:  2017-05-03

4.  Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement.

Authors:  Alejandro Rosell Castillo; Aglecio Luiz de Souza; Sarah Monte Alegre; Yeelen Ballesteros Atala; Denise Engelbrecht Zantut-Wittmann; Heraldo Mendes Garmes
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-07       Impact factor: 5.555

5.  The effects of growth hormone on therapy resistance in cancer.

Authors:  Reetobrata Basu; John J Kopchick
Journal:  Cancer Drug Resist       Date:  2019-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.